CME vs JPM: Which Is the Better Dividend Stock?
As of July 2026, JPM (JPMorgan Chase & Co.) screens as the stronger dividend stock, winning 5 of 7 head-to-head metrics. CME offers the higher yield at 2.12%, CME has the higher dividend-safety score, and JPM trades at the larger discount to fair value (+110%).
| Metric | CME | JPM |
|---|---|---|
| Forward yield | 2.12% | 1.76% |
| Annual dividend | $5.20 | $6.00 |
| Payout ratio | 96% | 26% |
| Years of growth | 15 yr | 15 yr |
| 5-yr dividend growth | 8.0% | 9.0% |
| 5-yr total return | 21% | 113% |
| Dividend safety score | 90 (A) | 85 (A) |
| Fair value estimate | $232.74 | $717.24 |
| Upside to fair value | -5% | +110% |
| Frequency | quarterly | quarterly |
| Market cap | $88.6B | $900.8B |
| P/E ratio | 20.9 | 14.6 |
Higher yield
CME
2.12%
Safer dividend
CME
Grade A
Faster growth
JPM
9.0%
Better value
JPM
+110% upside
CME vs JPM — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.